Similar articles

• [Sclerosing peritonitis and practolol (Eraldin)].

  Algaard A, Knudsen O, Solheim KE. Algaard A, et al. Tidsskr Nor Laegeforen. 1976 Apr 30;96(12):696-7. Tidsskr Nor Laegeforen. 1976. PMID: 936122 Norwegian. No abstract available.
• [Sclersong peritonitis during practolol (Eraldine) therapy].

  Bendtzen K, Lyngborg K, Sandor E, Soborg M. Bendtzen K, et al. Ugeskr Laeger. 1975 Sep 15;137(38):2194-6. Ugeskr Laeger. 1975. PMID: 1166558 Danish. No abstract available.
• [Sclerosing peritonitis following the use of practolol (Eraldin)].

  Braam JI, Reisma K, Luiken HC, van Hees CA, Oeberius Kapteyn JL, Henneveld HE, Van Beugen L, Hensen A. Braam JI, et al. Ned Tijdschr Geneeskd. 1975 Jun 21;119(25):1000-5. Ned Tijdschr Geneeskd. 1975. PMID: 1143582 Dutch. No abstract available.
• Problems in the surgical management of sclerosing encapsulating peritonitis.

  Assalia A, Schein M, Hashmonai M. Assalia A, et al. Isr J Med Sci. 1993 Nov;29(11):686-8. Isr J Med Sci. 1993. PMID: 8270396 Review.
• Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis.

  Garosi G, Di Paolo N. Garosi G, et al. Adv Perit Dial. 2000;16:204-7. Adv Perit Dial. 2000. PMID: 11045294 Review.